NIH-funded research Sbir 2 grant

A New Device for Precise Delivery of Addiction Treatments

Official title: Oscillated Insertion Tool for Minimally Invasive, Low-Damage, Accurate Placement of Delivery Cannula to Improve Efficacy for DREADDS Therapy in Alcohol Addiction Treatment

Funded at Actuated Medical, INC. · NIH-11093475 · Data updated 2026-11-12

This project is developing a special device to accurately deliver new gene-based treatments for alcohol addiction.

More Addiction research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionActuated Medical, INC.
NIH-funded
Lab location1 site (Bellefonte, United States)
Project startSeptember 1, 2022
Project endMay 31, 2027
Funding year2025
Award (this year)$1,379,360
NIH project number5R44AA030512-03
Project IDNIH-11093475 on NIH RePORTER

Who could benefit from this research

Could help

This work is foundational for future treatments, so patients with alcohol addiction who might be candidates for advanced gene therapies could eventually benefit.

Less likely to help

Patients whose addiction is not related to the brain regions targeted by these specific gene therapies, or who are not candidates for such invasive procedures, may not directly benefit from this particular device.

What this research studies

We are working on an advanced device called the Oscillated Syringe for Intracranial Injections (OSII) system. This device is designed to place tiny tubes, called cannulas, very gently and precisely into the brain. The goal is to improve how drugs and gene therapies, like those using adeno-associated viruses (AAVs), are delivered for conditions such as alcohol addiction. By making delivery more accurate and less damaging, we hope these promising new treatments will work better for patients.

Why it matters

Potential benefit: If successful, this device could make advanced gene therapies for alcohol addiction more effective and safer by ensuring precise delivery to the brain.

How similar studies have gone: Current methods for delivering gene therapies to the brain have limitations in precision, and this project aims to overcome those challenges with a novel device.

Where this research is happening

  • Actuated Medical, INC.
    Bellefonte, United States
    Active

Researchers

  • Principal investigator: Bagwell, Roger Brooks — Actuated Medical, INC.
  • Study coordinator: Bagwell, Roger Brooks

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.